Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis' Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam) - Drugs.com MedNews
Links shared publicly online about this topic.
- 199total visits
Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis' Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam) - Drugs.com MedNews
In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I pharmacokinetic s
View full resource at drugs.com
Tags: Anxiety Medication, Nose, Drug, Valium, Science
Most Recently Shared on June 22, 2011 at 8:09 pm By:
Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis' Recently Announced Suc... http://bit.ly/kwbs1g #drug
Advertisement
